Literature DB >> 17486053

Pancreatic adenocarcinoma: update on the surgical pathology of carcinomas of ductal origin and PanINs.

Ralph H Hruban1, Noriyoshi Fukushima.   

Abstract

Pancreatic cancer is the fourth leading cause of cancer death in the US. Most pancreatic cancers are infiltrating ductal adenocarcinomas. The careful application of well-defined morphologic criteria can be used to differentiate between infiltrating ductal adenocarcinoma and reactive glands. While most pancreatic cancers are ductal adenocarcinomas, a number of histologically defined variants have been described. These are important to recognize because they have distinct clinical pathologic features. Pancreatic intraepithelial neoplasia (PanIN) is the presumed precursor lesion to infiltrating ductal adenocarcinoma, and PanIN lesions can mimic infiltrating cancer.

Entities:  

Mesh:

Year:  2007        PMID: 17486053     DOI: 10.1038/modpathol.3800685

Source DB:  PubMed          Journal:  Mod Pathol        ISSN: 0893-3952            Impact factor:   7.842


  40 in total

Review 1.  Molecular subtypes in cancers of the gastrointestinal tract.

Authors:  Maarten F Bijlsma; Anguraj Sadanandam; Patrick Tan; Louis Vermeulen
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2017-04-12       Impact factor: 46.802

2.  Pathologic complete response to neoadjuvant therapy in patients with pancreatic ductal adenocarcinoma is associated with a better prognosis.

Authors:  Qing Zhao; Asif Rashid; Yun Gong; Matthew H Katz; Jeffrey E Lee; Robert Wolf; Aparna Balachandran; Gauri R Varadhachary; Peter W Pisters; Hua Wang; Henry F Gomez; James L Abbruzzese; Jason B Fleming; Huamin Wang
Journal:  Ann Diagn Pathol       Date:  2011-11-03       Impact factor: 2.090

3.  CXCR2 signaling promotes secretory cancer-associated fibroblasts in pancreatic ductal adenocarcinoma.

Authors:  Mohammad Awaji; Sugandha Saxena; Lingyun Wu; Dipakkumar R Prajapati; Abhilasha Purohit; Michelle L Varney; Sushil Kumar; Satyanarayana Rachagani; Quan P Ly; Maneesh Jain; Surinder K Batra; Rakesh K Singh
Journal:  FASEB J       Date:  2020-05-26       Impact factor: 5.191

Review 4.  Evolution of Premalignant Disease.

Authors:  Kit Curtius; Nicholas A Wright; Trevor A Graham
Journal:  Cold Spring Harb Perspect Med       Date:  2017-12-01       Impact factor: 6.915

5.  Isoprenylcysteine carboxylmethyltransferase deficiency exacerbates KRAS-driven pancreatic neoplasia via Notch suppression.

Authors:  Helen Court; Marc Amoyel; Michael Hackman; Kyoung Eun Lee; Ruliang Xu; George Miller; Dafna Bar-Sagi; Erika A Bach; Martin O Bergö; Mark R Philips
Journal:  J Clin Invest       Date:  2013-11       Impact factor: 14.808

6.  Metformin alters the duodenal microbiome and decreases the incidence of pancreatic ductal adenocarcinoma promoted by diet-induced obesity.

Authors:  Tien S Dong; Hui-Hua Chang; Meg Hauer; Venu Lagishetty; William Katzka; Enrique Rozengurt; Jonathan P Jacobs; Guido Eibl
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2019-09-23       Impact factor: 4.052

Review 7.  Morphogenesis of pancreatic cancer: role of pancreatic intraepithelial neoplasia (PanINs).

Authors:  Jan-Bart M Koorstra; Georg Feldmann; Nils Habbe; Anirban Maitra
Journal:  Langenbecks Arch Surg       Date:  2008-02-19       Impact factor: 3.445

8.  Insights into the Role of microRNAs in Pancreatic Cancer Pathogenesis: Potential for Diagnosis, Prognosis, and Therapy.

Authors:  Mohammad Aslam Khan; Haseeb Zubair; Sanjeev Kumar Srivastava; Seema Singh; Ajay Pratap Singh
Journal:  Adv Exp Med Biol       Date:  2015       Impact factor: 2.622

9.  CpG island methylation profile of pancreatic intraepithelial neoplasia.

Authors:  Norihiro Sato; Noriyoshi Fukushima; Ralph H Hruban; Michael Goggins
Journal:  Mod Pathol       Date:  2007-12-21       Impact factor: 7.842

10.  Prevention of pancreatic cancer by the beta-blocker propranolol.

Authors:  Hussein A Al-Wadei; Mohammed H Al-Wadei; Hildegard M Schuller
Journal:  Anticancer Drugs       Date:  2009-07       Impact factor: 2.248

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.